MySmallCap (@tzack16) header
MySmallCap (@tzack16) profile picture

Small and micro-cap companies are often under-followed and/or under-valued. A Content Carnivores media account to share but never recommend anything.

Chicago, IL
Joined June 2009
Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)Photo by MySmallCap (@tzack16)
We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at b2idigital.com/3rd-annual-ro… GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and therapy for advanced head and neck cancer. Additional development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, and Marburg), malaria and Zika virus, as well as therapies for various solid tumors. (Source: Company Website 08.06.24) We look forward to seeing the continued results from David A. Dodd, Arban Domi, Mary Hauser, Susan Hensley, MS, RAC, Kelly McKee, Mark Newman, John Niles, Tom O'Brien, Sreenivasa Rao Oruganti, J. Marc Pipas, MD, Erica Raiden, Mark Reynolds, John W. Sharkey, Jeff Welch, Ashley Zuniga, PhD PMP and the entire GeoVax Labs, Inc. team! Thanks to the stellar team at ROTH for organizing this conference: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Amanda McAdams, Otilia "Charo" Montano, Benjamin Bowen, James Antonopoulos, Jason Wittes, Jonathan Aschoff, Ph.D., Boobalan Pachaiyappan, Ph.D. and many others ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA. For more information on ROTH, please visit roth.com. We hope you’ll be able to attend this pivotal event shaping the future of healthcare innovation.
3
19
12
2,893
Dr. John de Groot, MD Andersen Cancer Center on GBM Awareness Day buff.ly/2V1WVpk #GBMDay #Glioblastoma #braincancer $KTRA
1
4
MySmallCap retweeted
How genetic signature and biomarker tests are being used in the management of early-stage cancers - Sara Riordan, MS, CGC buff.ly/3vpuNsQ #biomarkers #testing #earlydetection #cancer #cancermanagement
MySmallCap retweeted
Pathway modeling translates the 27-gene immuno-oncology algorithm into bladder cancer - #AACR21 Poster buff.ly/3a0zO3d #AACR21 #DetermaIO #bladdercancer #cancer $OCX
3
2
MySmallCap retweeted
Kintara's VAL-083: A First-in-Class Bifunctional Alkylating Agent with Promising Activity in MGMT Promoter buff.ly/3qFAqSj #braintumors #GBM #ovariancancer $KTRA
MySmallCap retweeted
GeoVax has four vaccine candidates in the pipeline, including a “universal coronavirus vaccine” buff.ly/32VpyFL #vaccine #virus #pipeline #COVID-19 $GOVX
MySmallCap retweeted
Over 45,000 tests have been performed to evaluate blood volume with Daxor's BVA-100® blood test. buff.ly/3gll2WG #bloodvolume #diagnostic $DXR
MySmallCap retweeted
Register in Advance - KOL Call on Oncocyte's Proprietary DetermaRx™ and DetermaIO™ Molecular Tests For Cancer Treatment Selection buff.ly/2ItVkms #lungcancer #breastcancer #KOL #webinar #joinus #diagnostics $OCX
MySmallCap retweeted
Orbsat Reports Strong Global E-commerce Holiday Sales as people give the gift of staying in touch--no matter where you are. buff.ly/34f9AXZ #global #ecommerce #growth $OSAT @orbsatcorp
MySmallCap retweeted
How far does plastic float when it gets tossed in the ocean? buff.ly/2LnAc2g #plasticwaste #ocean @OrbsatCorp $OSAT
MySmallCap retweeted
Orbsat Reaches Multi-Year Milestone of Over 35,000 Satellite Enabled Messenger and Locator Beacon Units Sold Worldwide buff.ly/34f9AXZ #satellite #communication #milestone $OSAT @orbsatcorp
MySmallCap retweeted
Up to 750,000 patients may be eligible for immunotherapy each year, yet today more than half of these patients won't respond. buff.ly/3hnRd79 #webinar #immunotherapy #cancer #oncology $OCX
1
3
MySmallCap retweeted
Up to 750,000 patients may be eligible for immunotherapy each year, yet today more than half of these patients won't respond. buff.ly/31NzW18 #webinar #immunotherapy #cancer #oncology $OCX
MySmallCap retweeted
Excited to announce that Dr. Arthur Sands, CEO of Nurix Therapeutics has joined the prestigious line-up for this upcoming #oncology panel on Sept 9th! buff.ly/31gJ26d Register now! @cellohealth @StrandTx @DrSynbio @demycolton
1
2
Don't forget to register for the next #virtualsalon on #GeneTherapy on July 29th! Complimentary registration here! buff.ly/2BXp5bV Featuring @cellohealth @generationbio #TenayaTx #StrideBio #biotech #pharma #lifesciences
8
7
MySmallCap retweeted
Sorry to say you might have to pay. But it still sucks
So... @avis and @aarp questionable information here. Referral from AARP. Car Rented from AVIS. Car Returned. No damage paperwork. But a month later...BILL for damages that are not identified. What are they trying to pull here? Case#u476455092
MySmallCap retweeted
Salarius Went Public This Month to Take on the Fight for Childhood and Advanced Solid Tumor Cancers buff.ly/2Z3DhFF $SLRX #childhoodcancer #cancer #solidtumors
MySmallCap retweeted
Lassa virus' soft spot revealed buff.ly/2N2rkOf #Lassafever $GOVX Lassa vaccine candidate – pre-clin studies showed: 100% Protection, Single-Dose, Fast-track Phase I/II SBIR grant from @NIH, CDMPR grant from #DoD for Master Seed Virus @EOSaphire @ljiresearch
HIV cases in West Virginia county rise to 71 buff.ly/2H7pdoF GeoVax's #HIV vaccine is a significant leap forward towards a "functional cure" of the clade-B type HIV, found in the U.S. and Western Europe and is ready for a pivotal Phase 3 trial. $GOVX @3littleredbones
3
3